1 Goldstein, DA & Massry, SG (1978) Diabetic nephropathy: clinical course and effect of hemodialysis. Nephron 20, 286–296.
2 Weidmann, P, Boehlen, LM & de Courten, M (1993) Pathogenesis and treatment of hypertension associated with diabetes mellitus. Am Heart J 125, 1498–1513.
3 Steinberg, HO, Paradisi, G, Hook, G, et al. (2000) Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 49, 1231–1238.
4 West, I (2000) Radicals and oxidative stress in diabetes. Diabetes Med 17, 171–180.
5 Thomas, G & Ramwell, PW (1989) Streptozotocin: a nitric oxide-carrying molecule and its effects on vasodilation. Eur J Pharm 261, 279–280.
6 Briaud, I, Rouault, C, Bailbe, D, et al. (2000) Glucose induced insulin mRNA accumulation is impaired in islets from neonatal streptozotocin-treated rats. Horm Metab Res 32, 103–106.
7 Luo, J, Yperselle, MV, Rizkalla, SW, et al. (2000) Chronic consumption of short-chain fructo-oligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr 130, 1572–1577.
8 Trowell, HC (1972) Ischemic heart disease and dietary fiber. Am J Clin Nutr 25, 926–932.
9 Bingham, SA, Williams, DRR & Cummings, JH (1985) Dietary fiber consumption in Britain: new stimates and their relation to large bowel cancer mortality. Br J Cancer 5, 399–402.
10 Gibson, GR & Roberfroid, MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 1401–1412.
11 Van Loo, JP, Cousement, P, De Leenheer, L, et al. (1995) On the presence of inulin and oligofructose as natural ingredients in the western diet. Crit Rev Food Sci Nutr 35, 525–552.
12 Vazquez, MJ, Alonso, JL, Dominguez, H, et al. (2000) Xylooligosaccharides: manufacture and applications. Trends Food Sci Technol 11, 387–393.
13 Campbell, JM, Fahey, GC & Wolf, BW (1996) Selected indigestible Oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr 27, 130–136.
14 Hsu, CK, Liao, JW, Chung, YC, et al. (2004) Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. J Nutr 134, 1523–1528.
15 Yamashita, K, Kawai, K & Itakura, M (1984) Effects of fructooligosaccharides on blood glucose and serum lipids in diabetic subjects. Nutr Res 4, 961–966.
16 Imaizumi, K, Nakatsu, Y, Sato, M, et al. (1991) Effect of xylooligosaccharides on blood glucose, serum and liver lipid and cecal short chain fatty acid on diabetic rats. Agric Biol Chem 55, 199–205.
17 Sangeetha, PT, Ramesh, MN & Prapulla, SG (2002) Influence of media components and reaction parameters on the production of fructosyl transferase and fructooligosaccharides. Sci Aliment 22, 277–287.
18 Aachary, AA & Prapulla, SG (2008) Corn-induced endo-1, 4-β-d-xylanase of Aspergillus oryzae MTCC 5154: production and characterization of xylobiose from Glucuronoxylan. J Agric Food Chem 56, 3981–3988.
19 Jeong, KJ, Park, IY, Kim, MS, et al. (1998) High-level expression of an endoxylanase from gene Bacillus sp. in Bacillus subtilis DB104 for the production of xylobiose from xylan. Appl Microbiol Biotechnol 50, 113–118.
20 Huggett, ASG & Nixon, DA (1957) Use of glucose oxidase, peroxidase and O-dianisidine in the determination of blood glucose and urinary glucose. Lancet 273, 366–370.
21 Bradford, MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Chem 72, 248–254.
22 Oser, BL (1965) In Hawk's Physiological Chemistry, 14th ed., . New Delhi: McGraw Hill Publishing Co.
23 Oser, BL (1965) In Hawk's Physiological Chemistry, 14th ed., . New Delhi: McGraw Hill Publishing Co.
24 Wyebenga, DR, Di Giorgio, J & Pileggi, VJ (1971) Manual and automated methods for urea nitrogen measurement in whole serum. Clin Chem 17, 891–895.
25 Monnier, VM & Cerami, A (1981) Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 211, 491–493.
26 Rudel, LL & Morris, MD (1973) Determination of cholesterol using o-phthalaldehyde. J Lipid Res 14, 363–366.
27 Takahara, S, Hamilton, BH, Nell, JV, et al. (1960) Hypocatalasemia, a new genetic carrier state. J Clin Invest 29, 610–619.
28 Racker, E (1955) Glutathione reductase from bakers' yeast and beef liver. J Biol Chem 217, 855–865.
29 Mabel, MJ, Sangeetha, PT, Platel, K, et al. (2008) Physiochemical characterization of fructooligosaccharides and evaluation of their suitability as a potential sweetener for diabetes. Carbohydr Res 343, 56–66.
30 Okazaki, M, Fujikawa, S & Matsumoto, N (1990) Effect of xylooligosaccharides on the growth of bifidobacteria. Bifidobact Microflora 9, 77–86.
31 Okazaki, M, Koda, H, Izumi, R, et al. (1991) In vitro digestibility and in vivo utilization of xylobiose. J Jpn Soc Nutr Food Sci 44, 41–44.
32 Kleessen, B, Hartmann, L & Blaut, M (2001) Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Br J Nutr 86, 291–300.
33 Venters, CS, Vorster, HH & Cummings, JH (1990) Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. Am J Gastroenterol 85, 549–553.
34 Laurent, C, Simoneau, C, Marks, L, et al. (1995) Effect of acetate and propionate on fasting hepatic glucose production in humans. Eur J Clin Nutr 49, 484–491.
35 Sheu, WH-H, Lee, I-Te, Chen, W, et al. (2008) Effects of xylooligosaccharides on type 2 diabetes mellitus. J Nutr Sci Vitaminol 54, 396–401.
36 van Bennekum, AM, Nruyen, DV, Schulthess, G, et al. (2005) Mechanisms of cholesterol-lowering effect of dietary insoluble fibres: relationships with intestinal and hepatic cholesterol parameters. Br J Nutr 95, 331–337.
37 Williams, CM (1999) Effects of inulin on lipid parameters in humans. J Nutr 129, Suppl. 1, S1471–S1473.
38 Kok, N, Roberfroid, M, Robert, A, et al. (1996) Involvement of lipogenesis in the lower VLDL secretion induced by oilgofructose in rats. Br J Nutr 76, 881–890.
39 Beylot, M (2005) Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr 93, Suppl. 1, S163–S168.
40 Younes, H, Garleb, K, Behr, S, et al. (1995) Fermentable fibers or oligosaccharides reduce urinary nitrogen excretion by increasing urea disposal in the rat cecum. J Nutr 125, 1010–1016.
41 Henri, K, Mule, C, Svend-Aage, J, et al. (1990) Relationship between serum cholesterol and diabetic nephropathy. Lancet ii, 1300–1304.
42 Baynes, JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 30, 405–412.